Momenta Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Momenta Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Momenta Pharmaceuticals Inc Strategy Report
- Understand Momenta Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Momenta Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP3906257A4 | Search Report | VERFAHREN ZUR HERSTELLUNG VON USTEKINUMAB | C07K16/244; C07K2317/14; C07K2317/21; C07K2317/31; C07K2317/41; C07K2317/76 | September 14, 2022 |
KR1020220119362A | Application | CD38을 표적으로 하는 조작된 Fc-항원 결합 도메인 작제물과 관련된 조성물 및 방법 | A61K2039/505; A61P35/02; C07K16/2896; C07K2317/52; C07K2317/64; C07K2317/72; C07K2317/732; C07K2317/734 | August 29, 2022 |
US20220267413A1 | Application | Methods For The Treatment Of Neurodegeneration | A61K2039/505; C07K16/00; C07K16/06; C07K2317/41; G01N33/6896 | August 25, 2022 |
US20220267388A1 | Application | ENGINEERED Fc CONSTRUCTS | A61K2039/577; A61K39/0008; A61P19/02; A61P37/06; C07K14/47; C07K2319/30 | August 25, 2022 |
US20220267460A1 | Application | COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS | C07K16/2827; C07K16/2887; C07K2317/24; C07K2317/41; C07K2317/522; C07K2317/524; C07K2317/526; C07K2317/53; C07K2317/55; C07K2317/72; C07K2317/732; C07K2317/734; C07K2317/92 | August 25, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward